Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women.

Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks ...

In a recent transaction reported to the Securities and Exchange Commission, Lewis (JO:LEWJ) H. Titterton Jr., a director at ...

At the conference last week in San Francisco, pharmaphorum editor-in-chief Jonah Comstock spoke with Vir Biotechnology CEO Marianne De Backer, who explained a bit more about what a dual-masked T-cell ...

Bhad Bhabie detailed her recent cosmetic procedure, sharing she got a nose job two months after opening up about her health.

Panelists discuss the findings from the DESTINY-Breast12 study, focusing on the efficacy and safety of trastuzumab deruxtecan in patients with HER2-low breast cancer and its potential to expand ...

Elinzanetant reduced vasomotor symptoms frequency and severity in women with or at high risk of HR-positive breast cancer in ...

At the start of the final Drop A Decade segment - which sees the show help a viewer 'drop a decade' - Nikki, 53, watched a video of 55-year-old Sandra asking her for help.

Legacy projects can help someone with metastatic breast cancer leave behind a lasting impact that will be remembered after ...

Individuals with advanced breast cancer at diagnosis are more likely to have prevalent cardiovascular disease.

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...